Blog Posts

Bruno Paiva: The Sanofi Spain PostASCO and PostEHA 2025 Webinar is Here

Bruno Paiva/X

Jun 25, 2025, 08:37

Bruno Paiva: The Sanofi Spain PostASCO and PostEHA 2025 Webinar is Here

Bruno Paiva, Director Flow Cytometry Core – CIMA LAB Diagnostics, shared a post on X:

“SAVE THE DATE

The Sanofi Spain PostASCO and PostEHA 2025 Webinar is here!

You can watch a summary of the most relevant results in multiple myeloma presented at ASCO and EHA
Date: June 26, 4:30 PM – 6:30 PM

Register.”

More posts featuring Sanofi.

ASCO25 Bruno Paiva cancer EHA25 OncoDaily Oncology

Aparna Parikh Has Been Named Program Director for the GI Medical Oncology Program at Mass General Brigham

Herbert Loong: Grateful for the Journey with ASCO International Affairs Committee

Unreleased Decision Letters From 2024–2025 Now Available - FDA

FDA Grants Breakthrough Therapy Designation to Zongertinib (HERNEXEOS) for First-Line Treatment of HER2-Mutant Advanced NSCLC

Hesham ElGhazaly: Global Inclusion in Clinical Trials at Vision Europe 2025

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Voices

Sep 5, 2025, 12:12

Jennifer Sullivan: Bringing "The Best of What We Are Wherever You Are"

Voices

Sep 5, 2025, 12:06

Armando Orlandi: Extraordinary Success for the 17th Breast Club!

Voices

Sep 5, 2025, 11:58

Roupen Odabashian: How WorkDone Health Tackles a $125B Healthcare Problem

Insight

Sep 5, 2025, 11:56

Eric Small on FY26 Budget: Saving Research Means Saving Lives

Voices

Sep 5, 2025, 11:45

Annalice Gandini: A Case Report on the Successful Use of Dual EGFR Blockade

Voices

Sep 5, 2025, 11:43

Conquering Underfunded and Rare Cancers Through Research - Conquer Cancer, the ASCO Foundation

Science

Sep 5, 2025, 11:34

Harpreet Singh: FDA Grants Accelerated Approval to Zongertinib for HER2-Mutant NSCLC

Voices

Sep 5, 2025, 11:26

Jia (Jenny) Liu: Excited to Share that NECTA PANNA-COTA Trial Reaches 100 Patients Enrolled

Voices

Sep 5, 2025, 11:25

Ivana Cattaneo: Excited to Lead European Government Affairs at BeOne Medicines

Voices

Sep 5, 2025, 11:18

Zodwa Dlamini: Advancing Brain Cancer Care: Precision, AI Innovation, and African Insights

Voices

Sep 5, 2025, 11:17

Narjust Florez: Women in Thoracic Oncology Event at WCLC

Voices

Sep 5, 2025, 11:08

Corinne Faivre-Finn: A Real Privilege to Attend the First Consensus Meeting on Non-Metastatic NSCLC in Barcelona